London, UK, 6 February 2007, Curidium Medica plc, (LSE: CUR) the personalized medicine company focused on bringing the right drug to the right patient, today announced that Executive Chairman, Gosse B. Bruinsma, M.D. will be presenting at The 10th Annual BIO CEO & Investor Conference in New York on 12 February at 11:45am Eastern Time in the New Amsterdam Suite at The Waldorf Astoria Hotel.
